SNO bio

SNO bio is understanding nitric oxide signaling pathways to create new therapeutic solutions. Aberrant protein S-nitrosylation (SNO) alters protein function in many disease pathways, however, unlike phosphorylation and ubiquitination, SNO has received little attention. SNO bio is using their platform to identify and prioritize nitrosylase and denitrosylase regulating proteins as targets for their proprietary drug discovery engine. The platform incorporates proteomics, functional genomics and machine learning and data science to match SNO enzymes to disease validated SNO sites. Many therapeutic areas can be addressed from oncology to inflammatory and metabolic disorders.

Jobs: